Literature DB >> 7139956

Double-antibody solid-phase radioimmunoassay for blood bradykinin.

M D Nielsen, F Nielsen, A M Kappelgaard, J Giese.   

Abstract

A solid phase radioimmunoassay for the determination of blood bradykinin has been developed. Highly specific antibodies against bradykinin were raised in rabbits after coupling the peptide to thyroglobulin. Iodination of [Tyr8]-bradykinin was carried out with a chloramine-T procedure resulting in a tracer with high specific activity. Bradykinin was isolated in the following way: blood was sampled directly into acetone, and lipids were removed by extraction with petroleum either (40-60 degrees C). The final purification was made on QAE-Sephadex A-25 at pH 7.4. The mean recovery of added [125I-Tyr8]-bradykinin was 28% with a sample volume of 6 ml whole blood. The sensitivity of the radioimmunoassay was 1.25 pg/tube or 3 pg/ml blood. The reproducibility of the method is satisfactory with a between-assay coefficient of variation below 16%. Levels found in venous blood were below 3 pg bradykinin/ml in normal persons.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139956     DOI: 10.1016/0009-8981(82)90191-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Mass spectrometric study of variation in kinin peptide profiles in nasal fluids and plasma of adult healthy individuals.

Authors:  Tanja Gangnus; Anke Bartel; Bjoern B Burckhardt
Journal:  J Transl Med       Date:  2022-03-29       Impact factor: 5.531

2.  Targeted LC-MS/MS platform for the comprehensive determination of peptides in the kallikrein-kinin system.

Authors:  Tanja Gangnus; Bjoern B Burckhardt
Journal:  Anal Bioanal Chem       Date:  2021-03-10       Impact factor: 4.142

3.  Factors associated with COVID-19 pandemic induced post-traumatic stress symptoms among adults living with and without HIV in Nigeria: a cross-sectional study.

Authors:  Morenike Oluwatoyin Folayan; Olanrewaju Ibigbami; Maha ElTantawi; Giuliana Florencia Abeldaño; Eshrat Ara; Martin Amogre Ayanore; Passent Ellakany; Balgis Gaffar; Nuraldeen Maher Al-Khanati; Ifeoma Idigbe; Anthonia Omotola Ishabiyi; Mohammed Jafer; Abeedah Tu-Allah Khan; Zumama Khalid; Folake Barakat Lawal; Joanne Lusher; Ntombifuthi P Nzimande; Bamidele Emmanuel Osamika; Bamidele Olubukola Popoola; Mir Faeq Ali Quadri; Mark Roque; Anas Shamala; Ala'a B Al-Tammemi; Muhammad Abrar Yousaf; Jorma I Virtanen; Roberto Ariel Abeldaño Zuñiga; Joseph Chukwudi Okeibunor; Annie Lu Nguyen
Journal:  BMC Psychiatry       Date:  2022-01-21       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.